Skip to main content
Equibles

FRANKLIN RESOURCES INC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 38777 San Mateo, CA
Back to SUPN Full portfolio

Position in SUPN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,966,790
-$476,274 QoQ
Shares Held
85,289
-0.8% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 335 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. SUPN ranks #17 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 340,275 $184,371,197
2 INDV
Indivior Pharmaceuticals, Inc.
 3,316,358 $136,070,166
3 NBIX
Neurocrine Biosciences Inc
 553,068 $93,214,076
4 VTRS
Viatris Inc
 5,658,439 $89,856,006
5 ZTS
Zoetis Inc.
 912,367 $65,562,688
6 ALKS
Alkermes plc.
 1,170,242 $61,320,679
7 AMLX
Amylyx Pharmaceuticals, Inc.
 2,950,225 $52,986,040
8 RDY
Dr Reddys Laboratories Ltd
 2,844,583 $41,218,006

All Filings in SUPN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,966,790 85,289
2026-03-31 $4,443,064 85,956
2025-12-31 $4,523,593 91,018
2025-09-30 $4,558,352 95,383
2025-06-30 $1,256,228 39,855
2025-03-31 $1,243,124 37,958
2024-12-31 $1,142,944 31,608
2024-09-30 $934,805 29,981
2024-06-30 $745,255 27,860
2024-03-31 $840,571 24,643
2023-12-31 $744,219 25,716
2023-09-30 $794,510 28,818
2023-06-30 $877,900 29,205
2023-03-31 $202,198 5,581